- Home
- EVOK vs MTNB Comparison
EVOK vs MTNB Comparison
Compare EVOK & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- MTNB
- Stock Information
- Founded
- EVOK 2007
- MTNB 2013
- Country
- EVOK United States
- MTNB United States
- Employees
- EVOK N/A
- MTNB N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- MTNB Health Care
- Exchange
- EVOK Nasdaq
- MTNB Nasdaq
- Market Cap
- EVOK 4.2M
- MTNB 3.6M
- IPO Year
- EVOK 2013
- MTNB N/A
- Fundamental
- Price
- EVOK $2.65
- MTNB $0.92
- Analyst Decision
- EVOK
- MTNB Hold
- Analyst Count
- EVOK 0
- MTNB 1
- Target Price
- EVOK N/A
- MTNB N/A
- AVG Volume (30 Days)
- EVOK 18.7K
- MTNB 539.0K
- Earning Date
- EVOK 08-12-2025
- MTNB 08-13-2025
- Dividend Yield
- EVOK N/A
- MTNB N/A
- EPS Growth
- EVOK N/A
- MTNB N/A
- EPS
- EVOK N/A
- MTNB N/A
- Revenue
- EVOK $11,594,083.00
- MTNB N/A
- Revenue This Year
- EVOK $57.82
- MTNB N/A
- Revenue Next Year
- EVOK $59.12
- MTNB N/A
- P/E Ratio
- EVOK N/A
- MTNB N/A
- Revenue Growth
- EVOK 89.89
- MTNB N/A
- 52 Week Low
- EVOK $1.94
- MTNB $0.47
- 52 Week High
- EVOK $12.32
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- EVOK 39.39
- MTNB 55.38
- Support Level
- EVOK $2.46
- MTNB $0.87
- Resistance Level
- EVOK $2.84
- MTNB $1.04
- Average True Range (ATR)
- EVOK 0.28
- MTNB 0.10
- MACD
- EVOK -0.05
- MTNB -0.01
- Stochastic Oscillator
- EVOK 15.40
- MTNB 24.61
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.